Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.37 Insider Own9.15% Shs Outstand39.17M Perf Week2.69%
Market Cap843.62M Forward P/E- EPS next Y-1.32 Insider Trans-0.43% Shs Float35.84M Perf Month-1.25%
Income-53.42M PEG- EPS next Q-0.37 Inst Own103.73% Short Float8.35% Perf Quarter34.95%
Sales185.49M P/S4.55 EPS this Y3.63% Inst Trans-0.56% Short Ratio5.04 Perf Half Y112.20%
Book/sh3.73 P/B5.73 EPS next Y5.20% ROA-20.87% Short Interest2.99M Perf Year-33.14%
Cash/sh4.42 P/C4.84 EPS next 5Y16.20% ROE-35.04% 52W Range6.08 - 34.13 Perf YTD74.33%
Dividend Est.0.13 (0.59%) P/FCF- EPS past 5Y-3.21% ROI-23.21% 52W High-37.33% Beta1.49
Dividend TTM- Quick Ratio9.62 Sales past 5Y40.27% Gross Margin73.31% 52W Low251.81% ATR (14)1.10
Dividend Ex-Date- Current Ratio11.05 EPS Y/Y TTM8.23% Oper. Margin-30.89% RSI (14)51.79 Volatility5.35% 5.06%
Employees474 Debt/Eq0.57 Sales Y/Y TTM23.04% Profit Margin-28.80% Recom2.44 Target Price20.71
Option/ShortYes / Yes LT Debt/Eq0.56 EPS Q/Q15.73% Payout- Rel Volume0.91 Prev Close22.22
Sales Surprise8.54% EPS Surprise10.56% Sales Q/Q20.81% EarningsApr 30 AMC Avg Volume593.83K Price21.39
SMA20-1.39% SMA507.04% SMA20042.08% Trades Volume540,539 Change-3.74%
Date Action Analyst Rating Change Price Target Change
Mar-07-24Upgrade Argus Hold → Buy $24
Jan-19-24Upgrade Stifel Hold → Buy $9 → $20
Jan-03-24Initiated Lake Street Buy $20
Oct-24-23Upgrade Wolfe Research Underperform → Peer Perform
Oct-11-23Downgrade Stifel Buy → Hold $45 → $12
Oct-11-23Downgrade CL King Buy → Neutral
Oct-11-23Downgrade Citigroup Buy → Sell $35 → $8
Oct-11-23Downgrade B. Riley Securities Buy → Neutral $54 → $14
Sep-21-23Downgrade Argus Buy → Hold
Sep-06-23Initiated Oppenheimer Outperform $30
May-02-24 10:07AM
May-01-24 06:39AM
Apr-30-24 08:57PM
04:50PM Loading…
Apr-23-24 04:30PM
Apr-09-24 04:30PM
Apr-08-24 10:25AM
Apr-02-24 04:30PM
Mar-22-24 12:00PM
Mar-07-24 09:00PM
09:00AM Loading…
Mar-05-24 09:00AM
Feb-29-24 10:50AM
Feb-28-24 06:20PM
Feb-07-24 04:30PM
Jan-22-24 07:27AM
Dec-26-23 04:40AM
Dec-21-23 11:08PM
Dec-20-23 04:30PM
Dec-08-23 04:09AM
Nov-21-23 05:56PM
Nov-13-23 04:07PM
01:19PM Loading…
Nov-10-23 01:19PM
Nov-09-23 01:50AM
Nov-08-23 06:42PM
Nov-02-23 08:00AM
Nov-01-23 10:01AM
Oct-31-23 02:02PM
Oct-26-23 04:30PM
Oct-25-23 10:25AM
Oct-16-23 11:29AM
Oct-11-23 06:16PM
Oct-10-23 04:20PM
Sep-21-23 10:06AM
Sep-04-23 04:30PM
Aug-11-23 06:19AM
Aug-03-23 04:30PM
Aug-02-23 10:21AM
Aug-01-23 05:35PM
Jul-13-23 02:25AM
Jul-12-23 12:35PM
Jul-11-23 04:30PM
Jun-30-23 08:31AM
May-22-23 07:09AM
May-16-23 03:28AM
May-09-23 06:25PM
May-07-23 08:54AM
May-05-23 09:00AM
May-04-23 04:30PM
Apr-26-23 04:30PM
Apr-18-23 04:30PM
Mar-31-23 10:36AM
Mar-27-23 09:54AM
Mar-02-23 08:29PM
Mar-01-23 07:52AM
Feb-28-23 08:05PM
Feb-07-23 09:00AM
Jan-23-23 12:00PM
Jan-09-23 07:20AM
Dec-30-22 12:46AM
Dec-28-22 04:30PM
Dec-22-22 11:47AM
Dec-12-22 09:15AM
Dec-05-22 12:00PM
Nov-10-22 07:36AM
Nov-08-22 07:35PM
Nov-03-22 04:30PM
Nov-01-22 12:35PM
Oct-25-22 04:30PM
Oct-19-22 01:27PM
Oct-18-22 07:46PM
Oct-17-22 08:03PM
Silk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ballinger Kevin J.DirectorMar 05 '24Buy16.9911,700198,78317,807Mar 07 06:01 AM
Buchanan Lucas W.COO/CFOMar 05 '24Sale17.179,877169,578500,925Mar 05 07:51 PM
Davis Andrew S.Chief Commercial OfficerMar 05 '24Sale17.175,48194,103287,773Mar 05 06:25 PM
Ruedy RichardEVPClin&Reg.Affairs&QAMar 05 '24Sale17.173,80065,242205,711Mar 05 07:50 PM
Jones Marie L.VP, Finance and CAOMar 05 '24Sale17.172,60244,67476,894Mar 05 06:20 PM
Klemz Kevin MEVP/Chief Legal Officer/Sec.Mar 05 '24Sale17.172,49742,871165,194Mar 05 06:16 PM
Ruedy RichardEVPClin&Reg.Affairs&QAFeb 29 '24Sale22.253,00066,750170,837Mar 04 06:19 PM
Jones Marie L.CAO and VP, FinanceOct 27 '23Sale6.616564,33454,941Oct 30 06:53 PM
Buchanan Lucas W.COO/CFOOct 04 '23Sale15.222,66240,524435,848Oct 06 06:28 PM
Klemz Kevin MEVP/Chief Legal Officer/Sec.Aug 17 '23Sale20.111,53930,94238,797Aug 18 08:16 PM
Davis Andrew S.Chief Commercial OfficerAug 03 '23Sale22.136,587145,797109,534Aug 04 05:31 PM
Buchanan Lucas W.COO/CFOJul 28 '23Option Exercise5.429,64352,229215,725Jul 31 05:44 PM
Jones Marie L.CAO and VP, FinanceJul 20 '23Option Exercise6.112,00012,22048,002Jul 21 06:24 PM
Rogers Erica J.President and CEOJul 11 '23Option Exercise1.601,0001,600270,639Jul 13 06:34 PM
Rogers Erica J.President and CEOJul 11 '23Sale31.561,00031,560269,639Jul 13 06:34 PM
Davis Andrew S.Chief Commercial OfficerJul 06 '23Sale30.79692,124115,614Jul 10 05:39 PM